MAM
Shadowfax appoints Sumit Pilankar as VP of engineering & technology
Mumbai: Homegrown crowdsourced logistics platform Shadowfax Technologies on Friday announced the latest addition to its senior leadership team. To further strengthen the technology vertical and make a strategic move towards the larger business goals at Shadowfax, the company has appointed Sumit Pilankar as the vice president – engineering and technology.
With over 17 years of rich experience in the technology industry, Pilankar will be taking charge of spearheading the engineering and technology unit and will be reporting to Shadowfax Technologies, co-founder & CTO, Vaibhav Khandelwal.
His role will involve creating innovative tech-enabled solutions to power last-mile delivery services. Prior to joining Shadowfax, Pilankar had led technology intervention in various organisations like Flipkart, Holiday IQ, WordPoint Technologies, and Kudos Infomedia.
Sharing the vision for the company’s growth aligned to the latest developments, Khandelwal said, “We are a growing and dynamic company. Our core has always been delivering value to our customers and helping them create an enhanced experience for the end customers. At Shadowfax, we leverage technology to build best-in-class logistics solutions that are efficient, cost-effective, and agile to service a vast range of businesses thereby adding value to the lives of our partners and patrons. We are excited to welcome Sumit on board and continue to ameliorate this journey towards excellence.”
Expressing his thoughts on his new stint, Pilankar said, “I have been closely following the developments in the Indian logistics and supply chain industry and believe that technology has the potential to be the game-changer. The industry has been transforming from manual to data-driven decision making and this when coupled with the latest technologies will enhance the experiences for all stakeholders.”
MAM
Cipla appoints Achin Gupta as MD and global CEO
Veteran pharma leader with 20-plus years takes charge from 1 April 2026, succeeding current MD.
MUMBAI: Cipla’s next chapter just got a seasoned prescription because when it comes to leading a pharma giant, Achin Gupta knows exactly which dose delivers results. The Mumbai-based drugmaker announced on 23 February 2026 that Achin Gupta, currently global chief operating officer, will step up as managing director and global chief executive officer from 1 April 2026. He succeeds the outgoing leadership team and will steer Cipla’s worldwide operations, market expansion, operational efficiency, and innovation pipeline across its broad portfolio of generics, specialty drugs, and consumer healthcare treatments.
Gupta brings more than 20 years of pharmaceutical industry experience to the corner office. Before rejoining Cipla, he spent over eight years at Glenmark Pharmaceuticals in senior roles, having also worked there earlier between 2004 and 2012. His career path also includes key stints at Abbott Laboratories and management consulting firm A.T. Kearney, giving him a well-rounded view of global pharma strategy, operations, and growth.
In his current COO role, Gupta has already been deeply involved in streamlining Cipla’s supply chain, boosting manufacturing agility, and driving digital transformation moves that positioned the company strongly amid post-pandemic supply challenges and rising competition. As MD and Global CEO, he’ll now have full accountability for executing Cipla’s long-term vision, from deepening presence in key markets like the US, Europe, and emerging regions to accelerating R&D in complex generics and biosimilars.
The appointment comes at a pivotal time for Cipla, as the industry navigates pricing pressures, regulatory shifts, and the push for affordable innovation in chronic therapies. Gupta’s track record of scaling operations and delivering consistent performance makes him a logical internal choice to keep the momentum going.
For a company that’s long been a household name in affordable medicines, this leadership handoff is less about a big shake-up and more about steady continuity with fresh energy ensuring the next dose of growth is as effective as the last.
